INDRAMEDCO
Invest with MTF
Invest Now
Invest in Indraprastha Medical Corporation with 2.08X leverage
Performance
- Low
- ₹373
- High
- ₹387
- 52 Week Low
- ₹307
- 52 Week High
- ₹641
- Open Price₹387
- Previous Close₹387
- Volume233,858
- 50 DMA₹428.15
- 100 DMA₹453.54
- 200 DMA₹453.83
Investment Returns
- Over 1 Month -13.07%
- Over 3 Month -36.53%
- Over 6 Month -14.21%
- Over 1 Year -19.2%
Smart Investing Starts Here Start SIP with Indraprastha Medical Corporation for Steady Growth!
Indraprastha Medical Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 19.2
- PEG Ratio
- 0.9
- Market Cap Cr
- 3,516
- P/B Ratio
- 5.3
- Average True Range
- 17.01
- EPS
- 19.95
- Dividend Yield
- 1.2
- MACD Signal
- -22.62
- RSI
- 41.76
- MFI
- 42.81
Indraprastha Medical Corporation Financials
Indraprastha Medical Corporation Technicals
EMA & SMA
Current Price
₹383.50
-3.5
(-0.9%)
- Bearish Moving Average 11
- Bullish Moving Average 5
- 20 Day
- ₹390.94
- 50 Day
- ₹428.15
- 100 Day
- ₹453.54
- 200 Day
- ₹453.83
Resistance and Support
381.03
- R3 403.87
- R2 395.43
- R1 389.47
- S1 375.07
- S2 366.63
- S3 360.67
Indraprastha Medical Corporation Corporate Actions - Bonus, Splits, Dividends
Indraprastha Medical Corporation F&O
About Indraprastha Medical Corporation
- NSE Symbol
- INDRAMEDCO
- BSE Symbol
- 532150
- Managing Director
- Mr. Shivakumar Pattabhiraman
- ISIN
- INE681B01017
Similar Stocks to Indraprastha Medical Corporation
Indraprastha Medical Corporation FAQs
Indraprastha Medical Corporation share price is ₹383 As on 06 February, 2026 | 08:28
The Market Cap of Indraprastha Medical Corporation is ₹3515.7 Cr As on 06 February, 2026 | 08:28
The P/E ratio of Indraprastha Medical Corporation is 19.2 As on 06 February, 2026 | 08:28
The PB ratio of Indraprastha Medical Corporation is 5.3 As on 06 February, 2026 | 08:28
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.